The United States Patent and Trademark Office (USPTO) has published a patent application, US20260083773A1, concerning "Pegylated Menaquinol Compositions and Methods of Treatment." The application, filed by inventors Sam L. Nguyen and John M. Rudey on December 5, 2025, discloses novel isolated, stable, and biologically active pegylated menaquinol derivatives and their therapeutic applications for various diseases.

This publication represents a new patent application filing and does not impose immediate regulatory obligations on entities. However, it signals potential future intellectual property developments in the pharmaceutical sector related to menaquinol derivatives. Companies involved in drug development, particularly in areas related to vitamin K or its analogues, should monitor the progress of this patent application and related filings for potential licensing opportunities or competitive intelligence.